samedan logo

 
 
spacer
home > ict > autumn 2019 > a paradigm shift in data monitoring
PUBLICATIONS
International Clinical Trials

A Paradigm Shift in Data Monitoring





The clinical trials industry is changing, along with the management of trial data. Where once it would take weeks to see trial results, it is now possible to view data in real time directly from eSource platforms and mobile devices. Electronic data capture remains a fundamental part of data collection, with Big Data, artificial intelligence, patient centricity, new technologies, and machine learning being the current industry buzzwords. For those working in the industry, it can be a challenge to stay on top of the continuously advancing data management world. To address this, The Society for Clinical Data Management (SCDM) recently published a new whitepaper on the evolution of clinical data management (CDM) to clinical data science (CDS).

What is Clinical Data Science?

The SCDM defines CDS as “the strategic discipline enabling data driven Clinical Research approaches and ensuring subject protection as well as the reliability and credibility of trial results. Clinical Data Science encompasses processes, domain expertise, technologies, data analytics and Good Clinical Data Management Practices essential to prompt decision making throughout the life cycle of Clinical Research”.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


As CEO of CluePoints, François Torche holds a Master’s in Business Administration from the ICHEC School of Management, Belgium. Over the past 18 years in the pharma industry, François has held positions as a Statistical Programmer, SAS and JAVA Developer, and IT Project Leader for companies such as GSK, UCB, and IDDI. During his 10 year tenure with IDDI as an IT Specialist, he assisted in the development of the SMART™ engine and the underpinning of CluePoints.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Drive for generics sees Korea increasingly attractive to international pharma

Amsterdam, 31st July 2019: Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.
More info >>

White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement